Delaware HB21 amends Title 16 to classify tianeptine and its derivatives as Schedule I controlled substances.
Delaware HB21 amends Title 16 of the Delaware Code to classify tianeptine and its derivatives, including salts, isomers, and salts of isomers, as Schedule I controlled substances. This change applies to any material, compound, mixture, or preparation containing tianeptine, unless specifically excepted. The bill aims to regulate the substance more strictly by placing it in the highest category of controlled substances.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.